111 Shares Outstanding 2018-2023 | YI

111 shares outstanding from 2018 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
111 Annual Shares Outstanding
(Millions of Shares)
2023 84
2022 83
2021 83
2020 82
2019 82
2018 50
2017 36
111 Quarterly Shares Outstanding
(Millions of Shares)
2023-12-31 84
2023-09-30 85
2023-06-30 84
2023-03-31 84
2022-12-31 83
2022-09-30 83
2022-06-30 83
2022-03-31 83
2021-12-31 83
2021-09-30 83
2021-06-30 83
2021-03-31 83
2020-12-31 82
2020-09-30 82
2020-06-30 82
2020-03-31 82
2019-12-31 82
2019-09-30 82
2019-06-30 82
2019-03-31 82
2018-09-30 45
2018-06-30
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.111B $2.105B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $37.366B 20.52
Inspire Medical Systems (INSP) United States $4.612B 0.00
Axonics (AXNX) United States $3.446B 0.00
Hims & Hers Health (HIMS) United States $3.129B 0.00
10x Genomics (TXG) United States $2.980B 0.00
Olink Holding AB (publ) (OLK) Sweden $2.978B 0.00
IRhythm Technologies (IRTC) United States $2.950B 0.00
Enovis (ENOV) United States $2.875B 21.31
Azenta (AZTA) United States $2.743B 154.15
Privia Health (PRVA) United States $2.016B 112.67
Schrodinger (SDGR) United States $1.654B 0.00
Omnicell (OMCL) United States $1.398B 48.32
Phreesia (PHR) United States $1.393B 0.00
Standard BioTools (LAB) United States $0.746B 0.00
Fulgent Genetics (FLGT) United States $0.662B 0.00
Definitive Healthcare (DH) United States $0.649B 0.00
Talkspace (TALK) United States $0.467B 0.00
Clover Health Investments (CLOV) United States $0.442B 0.00
Health Catalyst (HCAT) United States $0.410B 0.00
Pulmonx (LUNG) United States $0.349B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.296B 0.00
Butterfly Network (BFLY) United States $0.217B 0.00
P3 Health Partners (PIII) United States $0.191B 0.00
Outset Medical (OM) United States $0.187B 0.00
American Well (AMWL) United States $0.145B 0.00
TruBridge (TBRG) United States $0.134B 7.19
MSP Recovery (LIFW) United States $0.107B 0.00
SHL Telemedicine (SHLT) Israel $0.075B 0.00
Future Health ESG (FHLT) United States $0.070B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.064B 0.00
Augmedix (AUGX) United States $0.059B 0.00
EUDA Health Holdings (EUDA) Singapore $0.057B 0.00
HeartBeam (BEAT) United States $0.055B 0.00
Zepp Health (ZEPP) China $0.054B 0.00
CareCloud (CCLD) United States $0.045B 0.00
Movano (MOVE) United States $0.042B 0.00
Akili (AKLI) United States $0.034B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.031B 0.00
Bullfrog AI Holdings (BFRG) United States $0.022B 0.00
Streamline Health Solutions (STRM) United States $0.020B 0.00
Cue Health (HLTH) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Syra Health (SYRA) United States $0.010B 0.00
Biotricity (BTCY) United States $0.010B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.005B 0.00
Healthcare Triangle (HCTI) United States $0.004B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.001B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00